Neuroscience Team Testing Novel Therapy for Parkinson’s Disease

At the University of Nebraska, the Nerbraska Neuroscience Alliance is testing the use of Leukine, an immune system booster in cancer patients, as an immune therapy in those with Parkinson’s Disease. The project, a joint collaboration between neurologists and neuroscientists, is designed to determine whether Leukine “can transform the immune system in Parkinson’s disease from one that causes harm to the brain to one that protects it, elicits nerve cell repair and ultimately affects disease symptoms,” as one investigator noted. Click here to read the full article.